×
0 0 0 0 0 0 0.00202429149797567 0.00202429149797567
Stockreport

NewLink's indoximod shows positive action in early-stage study in aggressive type of brain tumor; shares up 3% [Seeking Alpha]

NewLink Genetics Corp (NLNK)  More Company Research Source: Seeking Alpha
Last newlink genetics corp earnings: 2/27 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.linkp.com/investor-relations
PDF NewLink Genetics ( NLNK ) is up on below-average volume on its announcement of updated data from a Phase 1 clinical trial assessing indoximod + front-line radiation + maintenance chemo in patients with newly diagnosed diffuse intrinsic pontine glioma (DIPG), a treatment-resistant and aggressive type of tumor that starts in the brain stem. The results were presented at the International Symposium of Pediatric Neuro-Oncology Annual Meeting in Denver, CO. All 10 treated patients showed initial symptomatic improvement. Nine of the 10 remain on study, the longest being 8.5 months. Historically, median survival is only nine months. On the safety front, an unspecified subset of patients experienced adverse events, including inflammation, which were actively managed. See all stocks on the move » Now read: NewLink Genetics: Explicating The Changing Fundamentals Of A Potential Comeback » [Read more]

IMPACT SNAPSHOT EVENT TIME: NLNK
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
NLNK alerts

from News Quantified
Opt-in for
NLNK alerts

from News Quantified